This page includes the latest FDA filings for Titan Pharmaceuticals Inc. Currently, you will find the latest 100 filings for Premarket Notifications, Premarket Applications, De Novo Applications, and GUDID registrations.
USA | NASDAQ | TTNP | DUNS 807182720 |
Device Company | Device | Date |
---|---|---|
Titan Pharmaceuticals, Inc. | Prescription Medication | 2021-03-19 |
Titan Pharmaceuticals, Inc. | Prescription Medication | 2020-11-04 |
Titan Pharmaceuticals, Inc. | Prescription Medication | 2020-07-21 |
Titan Pharmaceuticals, Inc. | Prescription Medication | 2019-11-28 |
Titan Pharmaceuticals, Inc. | Prescription Medication | 2019-10-24 |
Titan Pharmaceuticals, Inc. | Probuphine | 2016-06-09 |
NCAGE Code | 47F74 | TITAN PHARMACEUTICALS, INC. |
CAGE Code | 47F74 | TITAN PHARMACEUTICALS, INC. |
S.A.M. Registration | 47F74 [807182720] | TITAN PHARMACEUTICALS, INC. |
SEC | 0000910267 | TITAN PHARMACEUTICALS INC of DELAWARE |